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The Value Chain Case for Health Care Reform—
A conference summary
by Sam Kahan, senior economist, and William A. Testa, vice president and director of regional programs
On April 24–25, 2007, the Federal Reserve Bank of Chicago and the Detroit Regional 
Chamber sponsored a two-day forum examining a “value chain” perspective of health care 
delivery in the U.S. The program discussed how a value chain evaluation might lead to 
improvement in health care quality, reduction in costs, and increased user accessibility.
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Health care costs in the U.S. are high and 
rising rapidly. The U.S. spent approxi-
mately $2 trillion on health care in 2005, 
nearly 15% of real gross domestic prod-
uct (GDP)—up from 5.9% in 1965 and 
currently among the highest in the world. 
More importantly, costs are rising rapidly 
with no hint of any slowing. Since 1990, 
medical care costs as measured by the 
Consumer Price Index (CPI) have risen 
at a compound annual rate of 4.6%, 
nearly 2 percentage points faster than 
the overall CPI. Without effective reforms 
in the health care system, such trends are 
likely to continue as the U.S. population 
ages and the scope of medical technology 
continues to broaden. 
In Michigan, providing more cost-effec-
tive and customer-attuned health care is 
especially important as the automotive 
industry—the state’s primary industry—
bears the hefty legacy health care costs 
of its retirees. This also implies that efﬁ  -
ciency improvements in health care may 
have profound effects on Michigan’s 
competitiveness. Currently, the state is 
burdened with both a slowly growing 
economy and an aging population. At 
the conference, academics, health care 
providers, insurers, employers, labor 
union representatives, and representa-
tives of various governmental authori-
ties gathered to discuss one particular 
approach to addressing the health care 
challenges in Michigan and across the 
nation—the “value chain.”
Michael Porter has popularized the 
term value chain to mean the entire 
production process from the input of 
raw materials to the output of the ﬁ  nal 
product consumed by the end-user.1 It 
is called a value chain because each link 
in the process adds some value before 
the product or service is delivered to the 
ultimate customer. Along the way, the 
particular actors involved—which may 
include government agencies, nonproﬁ  t 
organizations, and other agents—and 
the arrangements and incentives under 
which the process takes place help to 
determine the cost and quality features 
of the ﬁ  nal product or service. For value 
chains involving public sector inputs, 
such as health care, there are myriad 
policy options, cooperative agreements, 
regulatory regimes, and institutional 
arrangements available at various stages 
of the value chain. Such arrangements 
characterize the quality, cost, and vari-
ety of the ﬁ  nal product or service. In 
contrast, for many goods and services 
supplied by private ﬁ  rms, the value 
chain process, while complex, has its 
elements chieﬂ  y fashioned within or 
between private ﬁ  rms, operating with 
relatively fewer constraints than public 
sector entities. Two alternatives were presented as to who should be the 
ultimate decision-maker in health care: the consumer 
(patient) or the provider (hospital/physician).
In the private sector, the value chain of 
today’s automotive industry is often held 
up as an ideal. Today, the automotive 
value chain is a segmented string of auto-
motive assembly ﬁ  rms and autonomous 
parts suppliers, with each being highly 
specialized and focused on particular 
core competencies. Competition among 
ﬁ  rms at each stage imposes cost-effective 
production and product innovation. 
Despite this specialization and compe-
tition, greater overall cost-effectiveness 
of the ﬁ  nal automobile is also brought 
about by particular cooperative relations 
among ﬁ  rms along the value chain. 
Given the level of cooperation in this 
system, quality and competitive price 
information are communicated quickly 
upstream in the value chain. Consumers 
downstream also have ready information 
on the ﬁ  nal product’s quality and price. 
This availability of information along 
the value chain imposes market disci-
pline on many competing automakers, 
which must in turn exert discipline on 
their suppliers, while also acting coop-
eratively on speciﬁ  c preassembly activi-
ties, such as automotive design and 
production planning. 
In contrast to today’s automotive market, 
the partnerships in the markets for health 
care services have not given rise to cost-
efﬁ  ciencies and delivery innovation. 
Fundamentally, many health care ser-
vices are complex and only purchased 
intermittently, if at all. This means that, 
often, consumers are not well informed 
in their purchase decisions. Even if the 
consumer understands what to shop for, 
information on cost and quality among 
providers is often sparse. Many needs for 
health care services are associated with 
costly and unpredictable episodes of 
illness, so that the services are often 
paid for under insurance arrangements 
rather than with direct fees for services. 
But insurance often gives rise to especial-
ly difﬁ  cult “moral hazard” issues in the 
health care arena. That is, this “third 
party payer” arrangement may mean 
that consumers are motivated to over-
purchase some types of health care ser-
vices or to avoid price shopping that they 
might otherwise engage in if they were 
paying directly. Physicians and hospitals 
often act as informed agents for consum-
ers of sophisticated health care services, 
and they too may not be strongly moti-
vated to ration services on the basis of 
cost in third party payer systems or to 
tightly control the cost-efﬁ  ciency of their 
own operations. Also, a signiﬁ  cant part 
of health care responsibilities may fall 
on the consumers so that their behaviors 
in prevention, self-medication, and life-
style must often be considered in achiev-
ing desired outcomes. So, too, in the U.S., 
governments and nonproﬁ  t agencies 
commonly serve as direct health care 
providers or as insurers and regulators. 
Private sector employers often include 
health care insurance as part of their 
employee compensation package. Such 
arrangements thereby introduce yet 
more actors into health care transac-
tions and payments. 
Value chain overview
To open the proceedings, Robert Burns, 
Wharton School of the University of 
Pennsylvania, gave an overview of the 
value chain approach, noting that this 
approach has not been effective in the 
health care arena. Some of the reasons 
include an inability to create and coor-
dinate strategic alliances, a lack of in-
formation regarding value/cost at each 
link, and an insufﬁ  cient sharing of 
knowledge in health care. Attempts at 
vertical integration, whether initiated 
by providers, insurers, or employers, 
have largely proved ineffective, proba-
bly because the coordination costs ex-
ceeded the gains from agglomeration. 
The only partial success at vertical inte-
gration has been at the U.S. Department 
of Veterans Affairs’ Veterans Health 
Administration—an organization that 
by its very nature has greater control 
over the whole process from individual 
payer to service provider. 
Burns also suggested that better technol-
ogy should be used in many parts of the 
health care value chain to create greater 
efﬁ  ciencies. He said that approximately 
$554 billion, or 28%, of the nearly 
$2 trillion spent on health care is cur-
rently technology-related; and this area 
of spending is growing rapidly.
According to Burns, currently, physicians 
have the central role in the health care 
value chain. They are the decision-makers 
for many products, such as medical de-
vices and drugs, as well as for services at 
hospital-based programs and alternative 
sites, such as outpatient clinics. As a re-
sult, physicians’ preferences are the focus 
of attention by medical equipment and 
drug producers, and they are probably 
the key determinant of value. But Burns 
sees an increasing role for the payer in 
the value chain. Through an expanded 
collection of data on cost, utilization, and 
product and service performance, he 
argued that efﬁ  ciencies and cost savings 
can be discerned and the information 
dispersed to the health care providers 
and producers—and ultimately, to con-
sumers. While there has been a very re-
cent movement to gather data on the 
quality and cost of medical services, es-
pecially those of hospitals, there is still a 
dearth of comparative information on 
health care. Burns stated that the patient 
needs to be more active in the value chain 
process, particularly as an informed 
purchaser of goods and services. 
Pros and cons of value chain
Uwe E. Reinhardt, Princeton University, 
questioned whether the value chain con-
cept can be very helpful to the health 
care industry until society decides who 
should determine value. The concept of 
the value chain can be a highly useful 
analytical tool in many contexts, but it 
runs into a host of conceptual and meth-
odological problems if applied to health 
care. The driving force for change in well-
functioning value chains is competition 
to provide the best value to the ultimate 
customer. For health care in the U.S., 
two important questions in applying this 
framework are: Who should set the “val-
ue” in the value chain; and how should Charles L. Evans, President; Daniel G. Sullivan, 
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the value of services be determined (that 
is, by market forces or by some other pro-
cess)? These are open questions because 
health care is often viewed by some as 
a social good to be distributed to all who 
need it regardless of ability to pay, but 
by others as a private good. Under our 
current system, there are several poten-
tial candidates to be the ultimate cus-
tomer, Reinhardt said, including the 
individual patient, the insured person, 
the insurance company, the taxpayer, and 
the employer. Since they all have varying 
motivations and requirements, there will 
not necessarily be an alignment of values 
along the value chain. He buttressed his 
argument by noting that current spend-
ing on health care varies across regions 
and procedures by a wide margin. For ex-
ample, U.S. personal health care spend-
ing per capita in 1998 averaged $3,759, 
but it ranged from a low of $2,731 in Utah 
to a high of $4,810 in Massachusetts. 
Dean G. Smith and Leon Wyszewianski, 
both of the University of Michigan School 
of Public Health, and Jeffrey R. Taylor, 
Michigan Public Health Institute (MPHI), 
discussed the merits of the health care 
value chain approach. Smith noted that 
the purpose of the health care system is 
“not to minimize overall or total expen-
ditures but to deliver value to patients, 
that is, better health per dollar spent.” 
He argued that greater attention should 
be paid to the patient, particularly the 
ﬁ  nancial incentives needed to inﬂ  uence 
patient behavior. As an example, he not-
ed that, while lower co-payments tend to 
increase usage of drugs (statins in his 
example), there is a marked decline in 
usage by individual patients over time; 
by year three, only 10% of patients con-
tinue using statins (as directed by their 
physicians) if the co-payment is greater 
than $20, but slightly more than half con-
tinue when payments are less than $10. 
In this instance, there is apparently a 
need to provide patients with an incen-
tive to continue using medication. More 
generally, medication charges should be 
better aligned with potential future costs. 
An implication of this approach, to mini-
mize total costs over a patient’s lifetime, 
is that someone who is at low risk might 
have a high co-payment for treatment, 
while someone at high risk should pay 
little or maybe even receive a refund. 
Smith noted that the University of 
Michigan, in its role as an employer, is 
experimenting with funding similar pre-
ventive actions, which in the short run can 
be expensive but which in the long run 
may actually result in lower costs because 
the client base will be healthier. 
Wyszewianski observed that in the cur-
rent system the physician has a near 
monopoly in decision-making that is 
difﬁ  cult to change in several important 
ways. His experience has been that phy-
sicians are not fully aware of the array of 
alternative approaches or procedures 
available; are not always fully apprised 
of the effectiveness of procedures; and 
are sometimes reluctant to implement 
different methods. He pointed to the 
Greater Detroit Area Health Council’s 
Save Lives Save Dollars program that has 
adopted performance metrics and issued 
evidence-based guidelines as one way of 
lessening physicians’ reluctance to change. 
Taylor reported that a shift from a paper 
to an electronic form of recordkeeping 
by ﬁ  scal intermediaries, such as Michigan 
County Health Plans, to MPHI has re-
duced costs from $15 to about $6 per 
processing in the past two years. Electron-
ic recordkeeping enhances the search 
for Medicare eligibility, thereby reducing 
labor costs, errors, and time-to-service. 
Taylor estimated that this enhancement 
represents 1.3 million transactions per 
month and reﬂ  ects an annual cost saving 
of about $7.7 million. 
Perspectives from the value chain
Scott P. Serota, Blue Cross Blue Shield 
Association, argued that the future health 
care model should be much more con-
sumer centric and information driven. 
The insurer’s role in such a world would 
be to provide consumers with informa-
tion on the comparative quality of care 
by provider, institution, and even indi-
vidual physician; to assess the various 
procedures; and to provide the costs of 
alternatives. At the center of all this would 
be personal health records of consumers 
that would be electronically portable. 
Janet Olszewski, Michigan Department 
of Community Health, described how 
the state of Michigan is attempting to 
contain costs and maintain access. She 
noted that a government agency is not 
merely a purchaser of health services and 
products; rather, it is also a provider, reg-
ulator, convener (bringing interested 
parties together), and occupier of a 
“bully pulpit” for policy and process re-
form. One effort at cost containment 
involved the pooling of Michigan’s 
Medicaid purchases with those of other 
states. This enabled Michigan to slow 
the trend growth of expenditures and 
to experience an absolute drop in 
pharmaceutical expenditures of 5.2% 
in 2006. Health plan contracting was 
another area of success. The health plans 
were rated on their performance in 
areas such as children’s care and chronic 
illnesses (e.g., diabetes) and awarded 
bonuses for outstanding performance. 
Olszewski cited three keys to the success 
of health care in the future—namely, 
ensuring access to health care, especially 
to the uninsured; increasing the usage of 
health care information technology; and 
emphasizing beneﬁ  cial lifestyle practices. 
Vernice Davis Anthony, Greater Detroit 
Area Health Council, reported on her 
organization’s efforts to improve quality, 
accessibility, and cost-effectiveness in 
the health care arena under the rubric, 
Save Lives Save Dollars, which was mentioned earlier. She attributed the 
program’s success to the creation of a 
broad-based coalition consisting of busi-
ness, labor, health care, government, and 
consumer groups, which provided a crit-
ical mass of support for change. Rather 
than tackling all health care issues, this 
multistakeholder group selected speciﬁ  c 
target issues, such as diabetes, heart 
attack/heart failure, and surgical site 
infections. The targets were selected be-
cause of the potential for improvement, 
opportunity to reduce costs, and avail-
ability of measurable metrics. A major 
achievement was the agreement by the 
major participating health plans to focus 
on a common set of metrics and to pro-
vide physicians with ﬁ  nancial incentives 
for performance. Save Lives Save Dollars 
has created a website (www.gdahc.org/
save.asp) that reports on hospital quality 
as well as the performance metrics. With-
in a year, data on health plans and the 
performance of individual physicians 
will also become available. 
Peter W. Carmel, American Medical 
Association and New Jersey Medical 
School, presented the physician’s per-
spective. Carmel said that value criteria 
should be focused on the patient, the 
ultimate receiver of beneﬁ  ts, and orga-
nized around medical conditions and 
care cycles rather than speciﬁ  c proce-
dures or incidents. Further, the metric 
should be the value of improved health 
care outcome divided by cost. He argued 
that physicians should take the lead in 
making decisions on health care prod-
ucts and processes because they are aware 
of the best ways to safely cut waste, are 
best equipped to evaluate new technol-
ogy, and can implement change. He 
acknowledged that, under most current 
arrangements, costs, procedures, and 
the whole care cycle are largely hidden 
from physicians—a shortcoming that 
needs correction. 
Conclusion 
The value chain approach offers some 
merit as a framework for understanding 
decision-making in health care provi-
sion. In business sectors like advanced 
manufacturing, where value chains are 
observed to work well, conditions are 
often controlled by one or more prin-
cipal agents—such as competing auto 
assembly companies—which can man-
age the entire value chain so as to de-
liver ﬁ  nal products of high value at low 
cost. At the conference, two alternatives 
were presented as to who should be the 
ultimate decision-maker in health care: 
the consumer (patient) or the provider 
(hospital/physician). To be an effective 
principal agent, the consumer (patient) 
and the enabling agencies will need con-
siderable time and effort to build up the 
knowledge base and skills to access and 
assimilate information concerning price 
and quality. Insurers, nonproﬁ  ts, and 
governments also may play important 
roles in assisting consumers to obtain 
comparative information. 
Determination (and delivery) of the ap-
propriate health care services has always 
entailed trust between physician and 
patient. Physicians have the advantages 
of relevant and educated information to 
inform health care decisions, although 
they are often isolated from background 
administrative processes that generate 
signiﬁ  cant costs. Thus, like others in the 
chain, physicians would also beneﬁ  t from 
a broader understanding of the total 
health care cycle. 
The health care market is generally 
characterized by a lack of transparency 
and a shortage of information among 
all the agents along the value chain. 
Market participants need information 
on costs; quality of care; and availability 
of procedures, techniques, and equip-
ment. Many of the presenters described 
ways in which they were trying to increase 
the quantity and quality of information. 
Such efforts will be useful in stimulating 
competition and innovation where it is 
most needed.
1  Michael E. Porter, 1998, Competitive Advantage: 
Creating and Sustaining Superior Performance, 
New York: Free Press.